Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.

Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study. J Patient Rep Outcomes. 2023 Nov 10; 7(1):113.

View in: PubMed

subject areas

Adolescent
Antineoplastic Agents
Child
Clinical Trials, Phase III as Topic
Hodgkin Disease
Humans
Neurotoxicity Syndromes
Peripheral Nervous System Diseases
Quality of Life
Reproducibility of Results

authors with profiles

Tara O. Henderson